IRulya Therapeutics (IRLA) Other Non-Current Liabilities (2023 - 2026)
Powered by 
Analysis
IRulya Therapeutics (IRLA) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.29 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 51.96 Mn |
| Sep 30, 2025 | 76.84 Mn |
| Jun 30, 2025 | 75.04 Mn |
| Mar 31, 2025 | 117.95 Mn |
| Dec 31, 2024 | 57.38 Mn |
| Sep 30, 2024 | 110.22 Mn |
| Jun 30, 2024 | 120.55 Mn |
| Mar 31, 2024 | 56.10 Mn |
| Dec 31, 2023 | 111.90 Mn |
API Access
IRulya Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();